SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

            QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2003

                            Commission File #2-89616


                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
             (Exact name of registrant as specified in its charter)


                                     MONTANA

         (State or other jurisdiction of incorporation or organization)

                                   82-0369233
                      (IRS Employer Identification Number)

                7500 San Felipe, Suite 600, Houston, Texas 77063
               (Address of principal executive offices)(Zip Code)

                                  713-914-8138
                (Registrant's telephone no., including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes [X] No [ ]

The number of shares outstanding of the Company's common stock as of June 31,
2003 is shown below:

Title of Class Number of Shares Outstanding Common Stock, par value $.001 per
share 35,618,486

Documents Incorporated by Reference: None

<PAGE>


                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

                                   FORM 10-QSB

                                Table of Contents

PART  I -   FINANCIAL INFORMATION

Item  1  -  Financial Information

Item  2  -  Management's Discussion and Analysis of Financial Condition
            Operations

Item  3  -  Controls and Procedures


PART II  -  OTHER INFORMATION

Item  2  -  Changes in Securities and Use of Proceeds

Item  6  -  Exhibits and Reports on Form 8-K

SIGNATURES



                         PART I - FINANCIAL INFORMATION



ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS
The financial statements of the company are set forth beginning on page F-1.


                         PART I - FINANCIAL INFORMATION


ITEM 1. FINANCIAL STATEMENTS

AS USED HEREIN, THE TERM "COMPANY" REFERS TO CONSOLIDATED MEDICAL MANAGEMENT
INC. UNLESS OTHERWISE INDICATED. CONSOLIDATED UNAUDITED INTERIM FINANCIAL
STATEMENTS INCLUDING A BALANCE SHEET FOR THE COMPANY AS OF THE QUARTER ENDED
JUNE 30, 2003, STATEMENT OF OPERATIONS, AND STATEMENT OF CASH FLOWS FOR THE
INTERIM PERIOD UP TO THE DATE OF SUCH BALANCE SHEET AND THE COMPARABLE PERIOD OF
THE PRECEDING YEAR ARE ATTACHED AS PAGES 3 THROUGH 5 AND ARE INCORPORATED HEREIN
BY THIS REFERENCE.

2

<PAGE>
<TABLE>
<CAPTION>


                              [THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]

                                  CONSOLIDATED MINERALS MANAGEMENT, INC.
                                         (A MONTANA CORPORATION)
                                        CONSOLIDATED BALANCE SHEET
                                                (UNAUDITED)

                                                  ASSETS
                                                  ------

Current Assets                                                      June 30, 2003        December 31, 2002
--------------                                                      -------------        -----------------

<S>                                                                  <C>                    <C>
Cash                                                                 $     4,902            $    63,076
                                                                     -----------            -----------

     Total Current Assets                                                  4,902                 63,076
                                                                     -----------            -----------

Other Assets
Oil & Gas Properties - Non Producing                                 $         0                 65,322
Investment in Fuel Dist. Facility                                      2,000,000
Note Receivable                                                          350,000                      0
                                                                     -----------            -----------
     Total Other Assets                                                2,350,000                 65,322
                                                                     -----------            -----------

                  Total Assets                                       $ 2,354,902            $   128,398
                                                                     ===========            ===========


                             LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                             ----------------------------------------------

Current Liabilities


Notes Payable-Current Portion                                        $    25,767            $    25,767
Accounts Payable                                                         108,012                108,012
Accrued Expenses                                                         313,678                357,803
Convertible Debentures                                                   465,000                465,000
Debentures Payable                                                       350,000
                                                                     -----------            -----------

         Total Current Liabilities                                     1,262,457                956,582

Notes Payable - Long Term Portion                                         54,726                 54,726
Convertible Debentures                                                 2,000,000                   --
                                                                     -----------            -----------
         Total Long-Term Liabilities                                   2,054,726                 54,726
                                                                     -----------            -----------

         Total Liabilities                                           $ 3,317,183            $ 1,011,308

Commitments and Contingencies:

Stockholders' Equity
         Preferred Stock
              20,000,000 authorized shares, par value $.001
              no shares issued and outstanding

         Common Stock                                                $    35,618            $    28,683
         $0.001 par value, 50,000,000 shares authorized
         35,618,486 shares issued and outstanding as of
         March 31, 2003 and 28,679,436 shares issued
         and outstanding as of December 31, 2002

         Additional Paid-in-Capital                                    3,817,049              3,675,535
         Stock Subscription Receivable                                    (4,000)               (67,250)
         Retained Earnings (Deficit)                                  (4,810,948)            (4,519,878)
                                                                     -----------            -----------

            Total Stockholders' Equity (Deficit)                        (962,281)              (882,910)
                                                                     -----------            -----------

            Total Liabilities and Stockholders' Equity (Deficit)     $ 2,354,902            $   128,398
                                                                     ===========            ===========


3

<PAGE>

                                            CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                                   (A MONTANA CORPORATION)
                                             CONSOLIDATED STATEMENT OF OPERATIONS
                                                        (UNAUDITED)

                                              THREE MONTHS ENDED JUNE 30, 2003
                                              --------------------------------

                                             THREE MONTHS ENDED JUNE 30,             SIX MONTHS ENDED JUNE 30,
                                             ---------------------------             -------------------------
                                              2003                2002               2003                 2002
                                              ----                ----               ----                 ----

Revenues                                   $  15,042           $       0           $  15,042           $       0
---------

Operating Expenses
    Personnel Costs                           27,500               9,173              46,500              52,736
    Consulting                                     0               8,000               7,950             154,000
    Legal and Professional                    18,625                                  24,315              10,296
    Other Expenses                            49,961                                  53,432              11,409
                                           ---------           ---------           ---------           ---------

    Total Operating Expenses               $  96,086           $  19,680           $ 132,197           $ 228,441

Income (Loss) from Operations                (81,044)            (19,680)           (117,155)           (228,441)

Other Income (Expenses)
      Interest Expense                             0             (13,046)            (11,625)            (24,671)
                                           ---------           ---------           ---------           ---------

Income (Loss) before Income Taxes          $ (81,044)          $ (32,726)          $(128,780)           (253,112)

Income Tax Expense                                 0                   0                   0
                                           ---------           ---------           ---------           ---------


Net Income (Loss)                          $ (81,044)          $ (32,726)          $(128,780)          $(253,112)
                                           =========           =========           =========           =========

Net Income (Loss) per Share                $  (.0022)          $   (.002)          $  (.0036)          $  (.0169)
                                           =========           =========           =========           =========


4

<PAGE>


                                       CONSOLIDATED MEDICAL MANAGEMENT, INC
                                             (A MONTANA CORPORATION)
                                          CONSOLIDATED STATEMENT OF CASH
                                                 (UNAUDITED)
                                          THREE MONTHS ENDED JUNE 30

Cash Flows from Operating Activities:                                     2003                    2002
-------------------------------------                                     ----                    ----

     Net Income (Loss)                                                $  (128,780)            $  (253,112)
     Adjustments to Reconcile Net Income (Loss) to
          Net Cash Provided by Operating Activities:
             Depreciation and Amortization
             (Increase) Decrease in Investme                           (2,000,000)
             (Increase) Decrease in Receivab                             (350,000)               (158,836)
             (Decrease) Increase in Accounts Payable                            0                   5,012
             (Increase) Decrease in Interest                                    0
             (Increase) Decrease in Accrued                                47,977                  24,671
                                                                      -----------             -----------

          Net Cash Provided (Used) by Operating Activities            $(2,430,803)            $  (382,265)
                                                                      -----------             -----------

 Cash Flows from Investing Activities:

     Assets Disposed

          Net Cash Provided (Used) by Investing Activities            $                       $
                                                                      -----------             -----------


 Cash Flows from Financing Activities:
      Increase in Long-Term Debt                                        2,000,000
      Increase in Short-Term Debt                                         350,000                   9,741
      Increase in Paid in capital                                         141,514                 364,952
      Common Stock                                                          6,935
      Decrease in Stock Subscriptions Receivable                          (63,250)
                                                                      -----------             -----------

          Net Cash Provided (Used) by Financing Activities            $ 2,435,199             $   376,289
                                                                      -----------             -----------

Net Increase (Decrease) in Cash                                             4,396                  (5,976)

Cash, Beginning of period                                                     506                   5,470
                                                                      -----------             -----------

Cash, End of period                                                   $     4,902             $       506
                                                                      ===========             ===========

 Supplemental Disclosure of Cash Flow Information
       Cash Paid During the Period for:                               $         0             $         0
                                                                      ===========             ===========
          Interest

          Income Taxes                                                $         0             $         0
                                                                      ===========             ===========


5

</TABLE>

<PAGE>


Note 1 - Basis of Presentation
------------------------------

General
-------

The consolidated unaudited interim financial statements of the Company as of
June 30, 2003 and for the three months and six months ended June 30, 2003,
included herein have been prepared in accordance with the instructions for Form
10QSB under the Securities Exchange Act of 1934, as amended, and Article 10 of
Regulation S-X under the Securities Act of 1933, as amended. The December 31,
2002 Consolidated Balance Sheet was derived from audited financial statements,
but does not include all disclosures required by generally accepted accounting
principles. Certain information and note disclosures normally included in
financial statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such rules and regulations
relating to interim consolidated financial statements.

In the opinion of management, the accompanying consolidated unaudited interim
financial statements reflect all adjustments, consisting only of normal
recurring adjustments, necessary to present fairly the financial position of the
Company at June 30, 2003, and the results of their operations for the three and
six months ended June 30, 2003 and June 30, 2002, and their cash flows for the
three and six months ended June 30, 2003 and June 30, 2002.

The results of operations for such periods are not necessarily indicative of
results expected for the full year or for any future period. These financial
statements should be read in conjunction with the audited consolidated financial
statements as of December 31, 2002 and related notes included in the Company's
Form 10-KSB filed with the Securities and Exchange Commission.

                                  Organization

The Company was incorporated under the laws of the State of Montana on August
13, 1981. The Company ceased its mining operations in 1985, and discontinued all
business operations in 1990. In August of 2001, the Company decided to refocus
on the oil and gas industry and entered into several Letters of Intent only one
of which survived the due diligence process.


NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
---------------------------------------------------

ACCOUNTING METHOD
-----------------

Accounting policies of the Company conform to the generally accepted accounting
principles and reflect practices appropriate to the industry in which it
operates. The significant policies are summarized below.


                                   RECEIVABLES

The Company, through an S-8 offering, grants options and stock to several
individuals for stock. As of June 30, 2003 and December 31, 2002 there was
$4,000 and $67,250 owed to the Company for stock purchased through the S-8 stock
program.


6

<PAGE>


                      PROPERTY, EQUIPMENT AND DEPRECIATION

Expenditures for property, plant and equipment are recorded at cost. Renewals
and improvements, which extend the economic life of such assets, are
capitalized. Expenditures for maintenance, repairs and other renewals are
charged to expense. For major dispositions, the cost and accumulated
depreciation are removed from the accounts and any gain or loss in included in
the results of operations.

CASH FLOWS AND CONCENTRATION OF CREDIT RISK
-------------------------------------------

Cash consists principally of demand deposits at commercial banks. These
balances, as reflected in the bank's records, are insured by the Federal Deposit
Insurance Corporation up to $100,000. At December 31, 2002 and June 30, 2003,
the Company's deposits did not exceed the insured limits.

EARNINGS PER COMMON SHARE
-------------------------

The Company adopted Financial Accounting Standards (SFAS) No. 128, "Earnings Per
Share," which simplifies the computation of earnings per share requiring the
restatement of all prior periods.


Basic earnings per share are computed on the basis of the weighted average
number of common shares outstanding during each year.

Diluted earnings per share are computed on the basis of the weighted average
number of common shares and dilutive securities outstanding. Dilutive securities
having an anti-dilutive effect on diluted earnings per share are excluded from
the calculation. The Company does not have any dilutive securities as of June
30, 2003.

NOTE 3 - COVERTIBLE DEBENTURES AND NOTES PAYABLE
------------------------------------------------

The Company issued convertible debentures in 1998 that are subordinated to bank
debt and secured leases. The debentures are otherwise unsecured but are given a
preference over unsecured debt. The debentures include interest at fifteen (15%)
percent, interest is payable in monthly installments. Each debenture has a
conversion right for each holder to convert the debenture principal to shares of
the Company's common stock at the greater of $2.50 per share or ninety (90%)
percent of the bid price, whichever is greater on the date of conversion.
Accrued interest and any principal amount not converted to shares of stock will
be paid in cash at conversion. The debentures are due one year from date of
issue. All debentures issued in 1998 were due in 1999, and they are in default
as of June 30, 2003.

The Company issued convertible promissory notes payable in 1998. The notes are
unsecured and include interest at ten (10%) percent, interest is payable in
monthly installments. Each note has a conversion right for each holder to
convert the note's unpaid principal to shares of the Company's common stock
based on $2.50 per share, or a total of 90,000 at the note holder's discretion.
Accrued interest and any principal amount not converted to shares of stock will
be paid in cash at conversion. As of December 31, the company had issued and
outstanding $325,00 in debentures. The notes were due July 31, 1999, and they
are in default as of June 30, 2003.

7

<PAGE>


The Company has entered into an agreement with Spectrum Financial, Inc.
("Spectrum") whereby Spectrum will exchange shares it owns with the debenture
holder upon exercise of the debenture's conversion option, in satisfaction of
the Company's obligations under the conversion provisions. In exchange, Spectrum
will then receive an unsecured note payable from the Company (see Note 7) for
the face amount of the debenture surrendered. During the year ended December 31,
1998, Spectrum exchanged a total of 14,000 of its shares in connection with this
agreement and received five notes payable from the Company totaling $35,000.

         Total Convertible Debentures and Notes Payable         $   465,000
         Less: Current Portion                                     (465,000)
                                                                -----------
         Long-Term Portion                                      $         0
                                                                ===========

The Company issued a $2,000,000 convertible debenture on April 15, 2003 which is
unsecured and includes interest at 5% per annum. The debenture matures on April
15, 2006. It is convertible at the option of the holder after April 15, 2004
into $2.000.000 of Common stock at a cost of 70% of the average bid price for
the stock for the immediate twenty days before the exercise.

The Company issued a $350,000 debenture on April 15, 2003 which is unsecured and
includes interest at 5% per annum. The debenture matures on October 15, 2003.

NOTE 4 - COMMON AND PREFERRED STOCK
-----------------------------------

COMMON STOCK
------------

The Company's common stock is $0.001 par value, there are 50,000,000 shares
authorized as of December 31, 2002 and June 30, 2003, the Company had 28,679,436
and 35,618,486 shares issued and outstanding, respectively.

PREFERRED STOCK
---------------

In 1998, the Company amended its articles to authorize Preferred Stock. There
are 20,000,000 shares authorized with a par value of $0.001. The shares are
non-voting and non-redeemable by the Company. The Company further designated two
series of its Preferred Stock: "Series 'A' $12.50 Preferred Stock" with
2,159,193 shares of the total shares authorized and "Series 'A' $8.00 Preferred
Stock," with the number of authorized shares set at 1,079,957 shares. As of June
30, 2003 and December 31, 2002 there are no shares issued and outstanding.

8

<PAGE>


DIVIDENDS
---------

Dividends are non-cumulative, however, the holders of such series, in preference
to the holders of any common stock, shall be entitled to receive, as and when
declared payable by the Board of Directors from funds legally available for the
payment thereof, dividends in lawful money of the United States of America at
the rate per annum fixed and determined as herein authorized for the shares of
such series, but no more, payable quarterly on the last days of March, June,
September, and December in each year with respect to the quarterly period ending
on the day prior to each such respective dividend payment date. In no event
shall the holders of either series receive dividends of more than one percent
(1%) in any fiscal year. Each share of both series shall rank on parity with
each other share of preferred stock, irrespective of series, with respect to
dividends at the respective fixed or maximum rates for such series.

CONVERSION PROVISIONS
---------------------

Any holder of either series may convert any or all of such shares into shares of
common stock of the Company at any time. Said shares shall be convertible at a
rate equal to three (3) shares of common stock of the Company for each one (1)
share of Series "A" or $12.50 Preferred Stock. The Series "A" $12.50 Preferred
Stock shall be convertible, in whole or in part, at any time after the common
stock of the Company shall maintain an average bid price per share of at least
$12.50 for ten (10) consecutive trading days.

Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three
(3) shares of common stock of the Company for each one (1) share of Series "A"
$8.00 Preferred Stock. The Series "A" $8.00 Preferred Stock shall be
convertible, in whole or in part, at any time after the common stock of the
Company shall maintain an average bid price per share of at least $8.00 for ten
(10) consecutive trading days.

The preferential amount payable with respect to shares of either Series of
Preferred Stock in the event of voluntary or involuntary liquidation,
dissolution, or winding-up, shall be an amount equal to $5.00 per share, plus
the amount of any dividends declared and unpaid thereon.

Also see Note 3

NOTE 5 - COMMITMENT AND CONTINGENCIES
-------------------------------------

The company has not recognized any commitments or contingencies at this time.

The Company's financial statements are prepared using generally accepted
accounting principles applicable to a going concern, which contemplates the
realization of assets and liquidation of liabilities in the normal course of
business. However, the Company does not have significant cash or other material
assets, nor does it have an established source of revenues sufficient to cover
its operating costs that raises substantial doubt about its ability to continue
as a going concern. The stockholders/officers and or directors have committed to
advancing operating costs of the Company interest free.

9

<PAGE>


ITEM 2. MANAGEMENT DISCUSSION AND ANAYLSIS OF FINACIAL CONDITION OR PLAN OF
        OPERATIONS.

The following discussion should be read in conjunction with our unaudited
consolidated interim financial statements and related notes thereto included in
this quarterly report and in our audited consolidated financial statements and
Management's Discussion and Analysis of Financial Condition and Results of
Operations (MD&A") contained in our Form 10-KSB for the year ended December 31,
2002. Certain statements in the following MD&A are forward looking statements.
Words such as "expects", "anticipates", "estimates" and similar expressions are
intended to identify forward-looking statements. Such statements are subject to
risks and uncertainties that could cause actual results to differ materially
from those projected.

GENERAL

Consolidated Medical Management, Inc. ("CMMI"), was incorporated under the laws
of the State of Montana on August 13, 1981 under the name Golden Maple Mining
and Leaching Company, Inc. On May 23, 1998, we changed our name to Consolidated
Medical Management, Inc. In August 2001, the Company decided to refocus on the
oil and gas industry and are currently doing business as Consolidated Minerals
Management, Inc. CMMI's address was 5161 San Felipe, Suite 320, Houston, Texas
77056 until June 2003 when the Company moved offices to 7500 San Felipe, Suite
600, Houston, Texas 77063.

RESULTS OF OPERATIONS

CMMI secured funding that enabled the Company to drill two Nacatoch wells in
Caddo Parrish, Louisiana. In December 2002, CMMI sold their interest in the
Nacatoch Light #1 and Bell #7 wells for $75,000. CMMI has successfully raised
the capital to develop 10 additional Nacotoch wells in Caddo Parish, LA. A third
well has been drilled and the Company is awaiting the results.

The Company acquired a 5% working interest in PAR Minerals Corporation's Snake
Bite Prospect (Richardson #1) in Edwards County, Texas. CMMI has partnered with
PAR in an Ellenberger horizontal test. The well began generating revenue sales
on March 16, 2003. The interest in Snake Bite Prospect was sold in April, 2003.

On April 15, 2003 CMMI acquired a lien position in the assets of Palm Petroleum,
Inc. CMMI ultimately intends to acquire full title to the assets of Palm
Petroleum in the third quarter of 2003.

10

<PAGE>


COMPARISON OF QUARTER ENDED June 30, 2003 TO THE QUARTER ENDED June 30, 2002

For the quarter ended June 30, 2003, our net loss was $81,044 as compared to
$32,726 for the quarter ended June 30, 2002. The increase is related to an
increase in consulting fees incurred from assistance developing a focused
business plan and strategy for obtaining the debt or equity financing that we
will need to acquire energy prospects.


LIQUIDITY AND CAPITAL RESOURCES

The Company used funds from private placements received from investors to invest
in two oil and gas wells to operate the company. The Company sold their interest
in these two oil wells in April 2003.

Currently, the liabilities shown on the balance sheet are current trade
payables, and accrued expenses and convertible debenture expenses related to
financing activities when the Company was engaged in the delivery of turn-key
management services for the home health industry, predominately in south
Louisiana.

The Company's recurring negative financial results raise substantial doubt about
the Company's ability to continue as a going concern.

The Company currently anticipates that its existing cash and cash equivalents
balance will fund operations and continue energy development at the current
level of activity into the third quarter of 2003. The Company will need to raise
additional funds through additional debt or equity financing. There can be no
assurance that additional equity or debt financing will be available when needed
or on terms acceptable to the Company.

The market price of the Company's common stock has fluctuated significantly
since it began to be publicly traded in 1998 and may continue to be highly
volatile. Factors such as the ability of the Company to achieve development
goals, ability of the Company to profitably complete energy projects, the
ability of the Company to raise additional funds, general market conditions and
other factors affecting the Company's business that are beyond the Company's
control may cause significant fluctuations in the market price of the Company's
common stock. The market prices of the stock of many energy companies have
fluctuated substantially, often unrelated to the operating or research and
development performance of the specific companies. Such market fluctuations
could adversely affect the market price for the Company's common stock.

11

<PAGE>



                                     PART II
Pursuant to the Instructions on Part II of the Form 10-QSB, Items 1, 3, and 5
are omitted.


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None


ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

None


                                   SIGNATURES

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange
Act of 1934, the undersigned has duly caused this Form 10-QSB to be signed on
its behalf by the undersigned, there unto duly authorized, in the City of
Houston, Texas, on August 18, 2003.


CONSOLIDATED MEDICAL MANAGEMENT, INC.

By:  /s/ Timothy G. Byrd, Sr.

         Timothy G. Byrd, Sr.
         Chief Executive Officer, Acting Chief Accounting Officer, an

12

<PAGE>

                                 Certifications

I, Timothy G. Byrd, Sr., certify that:

1.   I have reviewed this quarterly report on Form 10-QSB of Consolidated
     Medical Management, Inc.;

2.   Based on my knowledge, this quarterly report does not contain any untrue
     statement of a material fact or omit to state a material fact necessary to
     make the statements made, in light of the circumstances under which such
     statements were made, not misleading with respect to the period covered by
     this quarterly report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this quarterly report, fairly present in all
     material respects the financial condition, results of operations and cash
     flows of the registrant as of, and for, the periods presented in this
     quarterly report;

4.   The registrant's other certifying officers and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

     a)   designed such disclosure controls and procedures to ensure that
          material information relating to the registrant, including its
          consolidated subsidiaries, is made known to us by others within those
          entities, particularly during the period in which this quarterly
          report is being prepared;

     b)   evaluated the effectiveness of the registrant's disclosure controls
          and procedures as of a date within 90 days prior to the filing date of
          this quarterly report (the "Evaluation Date"); and

     c)   presented in this quarterly report our conclusions about the
          effectiveness of the disclosure controls and procedures based on our
          evaluation as of the Evaluation Date;

5.   The registrant's other certifying officers and I have disclosed, based on
     our most recent evaluation, to the registrant's auditors and the audit
     committee of registrant's board of directors (or persons performing the
     equivalent functions):

     a)   all significant deficiencies in the design or operation of internal
          controls which could adversely affect the registrant's ability to
          record, process, summarize and report financial data and have
          identified for the registrant's auditors any material weaknesses in
          internal controls; and

     b)   any fraud, whether or not material, that involves management or other
          employees who have a significant role in the registrant's internal
          controls; and

6.   The registrant's other certifying officers and I have indicated in this
     quarterly report whether there were significant changes in internal
     controls or in other factors that could significantly affect internal
     controls subsequent to the date of our most recent evaluation, including
     any corrective actions with regard to significant deficiencies and material
     weaknesses.

Date: August 18, 2003

                                    /s/ Timothy G. Byrd, Sr.
13
<PAGE>


Certification of Chief Executive Officer and Acting Chief Accounting Officer of
Consolidated Medical Management, Inc. pursuant to Section 906 of the
Sarbanes-Oxley Act of 1992 and Section 1350 of 18 U.S.C. 63.
--------------------------------------------------------------------------------

I, Timothy G. Byrd, Sr., the Chief Executive Officer and Acting Chief Accounting
Officer of Consolidated Medical Management, Inc. hereby certify that to my
knowledge, Consolidated Medical Management's periodic report on Form 10-QSB for
the period ended March 31, 2003, fully complies with the requirements of Section
13(a) or 15 (d) of the Securities Exchange Act of 1934 and that information
contained in the periodic report on Form 10-QSB and the financial statements
contained herein fairly presents, in all material respects, the financial
condition and results of the operations of Consolidated Medical Management, Inc.

         Date:  August 18, 2003             /s/  Timothy G. Byrd, Sr.
                                                 -------------------------------
                                                 Timothy G. Byrd, Sr.,
                                                 Chief Executive Officer
                                                 Consolidated Medical Management
14
<PAGE>


Certification of Chief Executive Officer and Acting Chief Accounting Officer of
Consolidated Medical Management, Inc. pursuant to Section 906 of the
Sarbanes-Oxley Act of 1992 and Section 1350 of 18 U.S.C. 63.
--------------------------------------------------------------------------------

I, Timothy G. Byrd, Sr., the Chief Executive Officer and Acting Chief Accounting
Officer of Consolidated Medical Management, Inc. hereby certify that to my
knowledge, Consolidated Medical Management's periodic report on Form 10-QSB for
the period ended March 31, 2003, fully complies with the requirements of Section
13(a) or 15 (d) of the Securities Exchange Act of 1934 and that information
contained in the periodic report on Form 10-QSB and the financial statements
contained herein fairly presents, in all material respects, the financial
condition and results of the operations of Consolidated Medical Management, Inc.

   Date:  August 18, 2003                   /s/  Timothy G. Byrd, Sr.
                                                 -------------------------------
                                                 Timothy G. Byrd, Sr.,
                                                 Chief Executive Officer
                                                 Consolidated Medical Management
15